Memory Impairment Clinical Trial
Official title:
Can Donepezil Preserve Autobiographical Memory Post Electroconvulsive Therapy? A Randomized, Placebo-Controlled Trial
This randomized, placebo-controlled trial will evaluate the use of donepezil compared to placebo to reduce the risk of memory impairment after electroconvulsive therapy (ECT).
Electroconvulsive therapy (ECT) is a method used to treat a variety of psychiatric
conditions. An electrical current is distributed throughout the brain (Lisanby 2007) inducing
seizure activity in a controlled setting using neuromuscular blocking agents (Mirzakhani
2012) while the patient is under anesthesia (Deiner 2009). ECT is approved by the Food and
Drug Administration (FDA) for the following conditions: unipolar and bipolar depression,
manic and mixed states in bipolar disorder, schizophrenia, schizoaffective disorder,
schizophreniform disorder and catatonia (FDA executive summary). ECT is often used after
trials of psychotropic medications have failed (Kellner 2012).
Electroconvulsive therapy (ECT) is commonly associated with cognitive side effects that range
from anterograde and retrograde amnesia to issues with executive function, attention and
declines in information processing. Problems with autobiographical memory and recall for new
information appear to be affected the most. In addition, data suggests that the loss of
memory of autobiographical events may persist as long as six months. These issues may cause
patient adherence problems and potential relapses into previous psychiatric conditions.
Donepezil is an acetylcholinesterase inhibitor indicated for Alzheimer's Dementia and has
been shown to slow the progressive decline in cognition and memory in Alzheimer's Dementia.
It is hypothesized that donepezil will help to preserve memory and minimize the decline in
memory that is associated with the administration of ECT.
This study aims to determine if donepezil can minimize deficiencies in autobiographical
memory 4-5 weeks after ECT treatment has been started.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03896529 -
Neurobiological Mechanisms of Aging and Stress on Prospective Navigation
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT00736034 -
The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment
|
Phase 4 | |
Completed |
NCT04910399 -
Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging
|
N/A | |
Completed |
NCT02814526 -
Exercise in Adults With Mild Memory Problems
|
N/A | |
Recruiting |
NCT05289804 -
Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment
|
Phase 1/Phase 2 | |
Completed |
NCT04955457 -
BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women.
|
||
Completed |
NCT05033262 -
Our Care Wishes - Dementia
|
N/A | |
Recruiting |
NCT01919957 -
Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies
|
N/A | |
Not yet recruiting |
NCT01708200 -
A Comparison of the Effectiveness of Two Types of Memory Training Programs in People With a Diagnosis of Mental Illness.
|
N/A | |
Recruiting |
NCT04583215 -
Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05543681 -
IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's
|
Phase 2 | |
Active, not recruiting |
NCT03205709 -
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT02302482 -
Predictive Factors and Autonomy Level Change
|
N/A | |
Completed |
NCT02301247 -
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
|
N/A | |
Completed |
NCT01708304 -
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
|
N/A | |
Recruiting |
NCT06025877 -
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
|
||
Recruiting |
NCT05122598 -
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
|
Phase 2 | |
Completed |
NCT04473235 -
Better Memory With Literacy Acquisition Later in Life
|
N/A | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A |